搜索临床试验以:Selective Progesterone Receptor Modulators
总计37634个结果
-
American University of Beirut Medical Center主动,不招人
-
Ain Shams UniversityMisr University for Science and Technology完全的
-
Andrea DeCensiEuropean Institute of Oncology; Associazione Italiana per la Ricerca sul Cancro主动,不招人
-
Memorial Sloan Kettering Cancer CenterPharmacia完全的
-
The University of Hong KongQueen Mary Hospital, Hong Kong完全的
-
Austrian Breast & Colorectal Cancer Study GroupAstraZeneca完全的
-
Tulane University Health Sciences Center完全的
-
SanofiEuropean Organisation for Research and Treatment of Cancer - EORTC; Alliance Foundation Trials... 和其他合作者终止
-
British Columbia Cancer AgencyCanadian Cancer Society (CCS); NanoString Technologies, Inc.主动,不招人
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; North Central Cancer Treatment Group 和其他合作者完全的
-
Novartis Pharmaceuticals完全的激素受体阳性、HER2 阴性、晚期乳腺癌日本, 香港, 新加坡
-
Yale UniversityJohns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human... 和其他合作者完全的
-
California Pacific Medical Center Research InstitutePatient-Centered Outcomes Research Institute; University of Pittsburgh; University of Illinois... 和其他合作者主动,不招人
-
CHU de Quebec-Universite LavalGlaxoSmithKline完全的
-
Jennifer Lee Caswell-JinNational Cancer Institute (NCI); QED Therapeutics, Inc.终止
-
Azienda Ospedaliera Universitaria Integrata VeronaUniversity of Catania完全的
-
University of California, San FranciscoAmgen主动,不招人解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 复发性乳腺癌 | 浸润性乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性美国
-
Janssen Research & Development, LLC完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)终止
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey主动,不招人IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
National Cancer Institute, NaplesUniversity of Campania "Luigi Vanvitelli"主动,不招人
-
Galenika AD BeogradMedicinsko društvo za racionalnu terapiju Republike Srbije (MEDRAT)完全的
-
Novartis Pharmaceuticals完全的
-
Services Institute of Medical Sciences, Pakistan完全的
-
University Hospital, GhentUniversity Hospital, Antwerp; AZ Jan Palfijn Gent; Gedeon Richter Plc.; Our Lady of Lourdes Hospital...终止
-
University Hospital, Basel, Switzerland完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstitutePfizer完全的
-
The Netherlands Cancer InstituteGenentech, Inc.; EurocanPlatform; Rather完全的
-
National Cancer Institute (NCI)完全的复发性乳腺癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu 阴性 | HER2/Neu阳性 | 孕激素受体阴性 | 孕激素受体阳性 | IIIC 期乳腺癌 AJCC v6 | IV 期乳腺癌 AJCC v6 和 v7美国, 波多黎各
-
Nalagenetics Pte LtdIndonesia University; SJH Initiatives; MRCCC Siloam Hospitals Semanggi主动,不招人
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; NCIC Clinical Trials Group; Cancer and Leukemia Group...完全的